Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
grade D 42.53 0.14% 0.06
PFE closed up 0.14 percent on Friday, January 18, 2019, on 1.45 times normal volume.

Earnings due: Jan 29

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Flat
See historical PFE trend table...

Date Alert Name Type % Chg
Jan 18 20 DMA Resistance Bearish 0.00%
Jan 17 20 DMA Resistance Bearish 0.14%
Jan 16 Fell Below 20 DMA Bearish 1.00%
Jan 16 MACD Bearish Signal Line Cross Bearish 1.00%
Jan 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.47%
Jan 15 Crossed Above 20 DMA Bullish -0.47%
Jan 14 Fell Below 20 DMA Bearish 0.38%
Jan 14 Narrow Range Bar Range Contraction 0.38%
Jan 14 NR7 Range Contraction 0.38%
Jan 14 Inside Day Range Contraction 0.38%

Older signals for PFE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.
Is PFE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 46.47
52 Week Low 33.2
Average Volume 25,209,140
200-Day Moving Average 40.3339
50-Day Moving Average 43.4204
20-Day Moving Average 42.5885
10-Day Moving Average 42.74
Average True Range 0.9495
ADX 21.4
+DI 15.5978
-DI 23.2684
Chandelier Exit (Long, 3 ATRs ) 40.8815
Chandelier Exit (Short, 3 ATRs ) 43.2685
Upper Bollinger Band 43.9711
Lower Bollinger Band 41.2059
Percent B (%b) 0.48
BandWidth 6.492833
MACD Line -0.2462
MACD Signal Line -0.2455
MACD Histogram -0.0007
Fundamentals Value
Market Cap 252.95 Billion
Num Shares 5.95 Billion
EPS 1.37
Price-to-Earnings (P/E) Ratio 31.04
Price-to-Sales 4.06
Price-to-Book 3.64
PEG Ratio 2.40
Dividend 1.28
Dividend Yield 3.01%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 43.46
Resistance 3 (R3) 43.47 43.18 43.31
Resistance 2 (R2) 43.18 42.94 43.17 43.25
Resistance 1 (R1) 42.85 42.79 42.71 42.84 43.20
Pivot Point 42.56 42.56 42.48 42.55 42.56
Support 1 (S1) 42.23 42.32 42.09 42.22 41.86
Support 2 (S2) 41.94 42.17 41.93 41.81
Support 3 (S3) 41.61 41.94 41.76
Support 4 (S4) 41.60